-transparent.png){kind=logo}
Influenza vaccines (split, adsorbed, low nitrogen) of two different antigen concentrations (commercial production) were administered to 1,111 adult persons of both sexes. Up to five previous vaccinations had been given to the population under observation. Their reactions both local and general were not different in primo-vaccinees or boostered persons. Increasing numbers of previous vaccinations were not reflected by increasing rates of complaints. Disregarding immunization history, the group given the higher concentrated vaccine showed a lower rate of side effects while the lower antigen concentration produced a higher rate. The relevance of the observation that no sensitizing effect occurred in persons with up to five vaccinations may be a characteristic of split adsorbed influenza vaccines of high purity.
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
October 1980,
MMW, Munchener medizinische Wochenschrift,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
January 1976,
Infection,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
June 1981,
Die Medizinische Welt,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
February 2001,
The Japanese journal of veterinary research,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
January 1975,
Journal of biological standardization,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
March 2006,
Expert opinion on biological therapy,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
October 1974,
The Journal of infectious diseases,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
January 1975,
Developments in biological standardization,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
October 1980,
Schweizerische medizinische Wochenschrift,
W Hennessen, and
R Mauler, and
H Gruschkau, and
H G Lehmann
January 1974,
Archiv fur die gesamte Virusforschung,
